สำรวจทุกแง่มุมของการใช้ชีวิตร่วมกับโรคไต
A systematic review and meta-analysis compared multiple drug classes in type 1 diabetes (T1DM) patients for kidney markers and safety; results showed an overall reduction in urine…
A systematic review found limited and inconsistent evidence on the effects of SGLT2 inhibitors on bone health in CKD patients, with particularly scarce data in advanced CKD populations [1].
A single-arm meta-analysis of diabetic patients with biopsy-proven MASH found SGLT2 inhibitors were associated with improvements in multiple liver, metabolic, and histologic markers versus…
About 590 million adults have diabetes, and roughly 40% will develop diabetic kidney disease — the leading cause of dialysis worldwide.
Heart failure doesn't mean the heart has stopped — it means it can't pump enough for the body's needs.
เพิ่ม Beyond CKD ไปยังหน้าจอหลัก
เปิดใช้งานเหมือนแอป สามารถอ่านบทความและเครื่องมือที่เคยเปิดดูได้แม้ออฟไลน์